ETTX
Entasis Therapeutics Holdings Inc.
Pivotal Bioventure Partners Fund I, L.P. bought $5.1M of Entasis Therapeutics Holdings Inc.
10% owner
Bought$5,065,860
$15.00Price
337,724Shares
+40%Stake
What ETTX did for a copier
Prices for ETTX after this filing aren't in yet.
Pivotal Bioventure Partners Fund I, L.P.'s record
3 other buys on record. A record shows here once 3 of them have 3 months of prices.
We're building an app that can copy buys like this into your own brokerage. Join the waitlist
Traded Fri, Sep 28. Filed Tue, Oct 2, 5:39 PM ET, after the close. Not investment advice.